Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 2024-04-02 23:00
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj. 2024-02-26 21:30
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024 2024-02-14 16:33
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 2024-01-23 11:53
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform 2024-01-09 00:00
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 2023-12-18 09:49
GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia 2023-12-06 08:56
GC Biopharma establishes mRNA production facility in Hwasun, Korea 2023-12-01 16:31
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval 2023-11-06 09:11
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023 2023-10-11 08:49
GC Biopharma Signs Power Purchase Agreement with SK E&S 2023-10-10 14:20
FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura 2023-10-06 08:12
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community 2023-08-30 16:05
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 2023-08-25 15:14
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements. 2023-08-18 08:58
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent 2023-07-21 16:47
GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia 2023-06-02 08:35
GC Biopharma celebrates 'World Hemophilia Day' 2023-04-18 09:03
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology 2023-02-28 08:53
1 2